| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione manufacturers
- CD73-IN-3
-
- $58.00
-
2026-07-27
- CAS:2375815-63-5
- Purity: 99.76%
- Supply Ability: 10g
|
| | 5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Basic information |
| Product Name: | 5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione | | Synonyms: | 5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione;5-[6-Methyl-5-[(1S,2R)-2-propan-2-ylcyclopropyl]pyridazin-3-yl]-1H-pyrimidine-2,4-dione;EX-A4254;Inhibitor,cancer,CD73 IN 3,CD-73-IN-3,CD73IN3,CD73,Immunosuppression,tumor,inhibit;5-[5-[(1S,2R)-2-isopropylcyclopropyl]-6-methyl-pyridazin-3-yl]-1H-pyrimidine-2,4-dione;CD73-IN-3, 10 mM in DMSO;LY-3475070 ,S9867;CD73-IN-3 | | CAS: | 2375815-63-5 | | MF: | C15H18N4O2 | | MW: | 286.34 | | EINECS: | | | Product Categories: | | | Mol File: | 2375815-63-5.mol |  |
| | 5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Chemical Properties |
| density | 1.245±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (349.25 mM; Need ultrasonic) | | pka | 7.25±0.10(Predicted) | | form | Solid | | color | White to off-white | | InChI | InChI=1/C15H18N4O2/c1-7(2)9-4-11(9)10-5-13(19-18-8(10)3)12-6-16-15(21)17-14(12)20/h5-7,9,11H,4H2,1-3H3,(H2,16,17,20,21)/t9-,11+/s3 | | InChIKey | WHRUIISQCORGKK-KEGWAHOBNA-N | | SMILES | C([C@H]1C[C@@H]1C1=C(N=NC(C2=CNC(=O)NC2=O)=C1)C)(C)C |&1:1,3,r| |
| | 5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Usage And Synthesis |
| Uses | CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay). CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research[1]. | | References | [1] Robert Dean Dally, et al. Cd73 inhibitors. Patent WO2019168744 A1. |
| | 5-(5-((1S,2R)-2-isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Preparation Products And Raw materials |
|